Cell‐based therapy to reduce mortality from COVID ‐19: Systematic review and meta‐analysis of human studies on acute respiratory distress syndrome
Concise Review
[키워드] acute respiratory distress
acute respiratory distress syndrome
adipose
Administered
adverse event
Allogeneic
alveolar
ARDS
Bone marrow
Cell therapy
clinical
clinical study
Combined
comparison
contribute
COVID
COVID‐19
COVID‐19 infection
COVID‐19
cytokine
cytokine production
death
determine
edema
Inflammatory
inflammatory biomarker levels
Injury
intravenously
literature review
Lung compliance
Macrophage
membrane
menstrual blood
Mesenchymal stromal cells
Mild
modulate
Mortality
MSC
MSC therapy
MSCs
nine
PaO
Participants
patients with ARDS
performed
Potential treatment
Pulmonary function
Radiographic
reduce mortality
reduction
remodeling processe
reported
resolved
Serious Adverse Event
shown
statistical significance
stromal cell
syndrome
systematic review
T‐cell
therapy
tissue
Trial
umbilical
variant
yielding
[DOI] 10.1002/sctm.20-0146 PMC 바로가기 [Article Type] Concise Review
[DOI] 10.1002/sctm.20-0146 PMC 바로가기 [Article Type] Concise Review